Myocardial infarction with angiographically normal coronary arteries in the contemporary era

Yared G Terefe1, Ashutosh Niraj, Jyotiranjan Pradhan

  • 1Department of Internal Medicine, Wayne State University School of Medicine, Detroit, Michigan 48201, USA.

Coronary Artery Disease
|November 16, 2007
PubMed

Insights

Myocardial infarction with normal coronary arteries (MINC) patients experience lower mortality and reinfarction rates compared to those with single vessel disease. Left ventricular function predicts cardiac events in MINC patients.

Area of Science:

  • Cardiology
  • Internal Medicine
  • Clinical Research

Background:

  • Myocardial infarction with angiographically normal coronary arteries (MINC) is recognized, but outcomes and prognostic factors are not well-defined.
  • Limited literature exists on the clinical characteristics, etiologies, and outcomes of MINC.

Purpose of the Study:

  • To identify clinical characteristics and etiologies of MINC.
  • To determine outcome predictors in patients with MINC.

Main Methods:

  • Retrospective follow-up study of 58 MINC patients.
  • Comparison of MINC patients with myocardial infarction and single vessel coronary artery disease (MISVD) group.
  • Collection of clinical, risk factor, etiologic, and laboratory data; survival and cardiac event follow-up.

Main Results:

  • MINC patients had less hypercholesterolemia and ST elevation than MISVD patients.
  • Identified etiologies included hypercoagulopathy, connective tissue disorders, cocaine abuse, and Takotsubo cardiomyopathy.
  • MINC patients showed significantly lower rates of reinfarction and cardiovascular death; angina and heart failure were common events. Left ventricular ejection fraction independently predicted cardiac events.

Conclusions:

  • MINC is associated with reduced mortality and morbidity compared to myocardial infarction with single vessel disease.
  • Left ventricular function is a key independent predictor of adverse outcomes in MINC patients.
Abstract

Related Concept Videos

Ischemic Heart Disease: Overview01:17

Ischemic Heart Disease: Overview

Ischemic heart disease occurs when the heart's blood supply dwindles, causing an ominous lack of oxygen and nutrients. This deficiency, stemming from reduced or obstructed blood flow, spells danger, leading to heart muscle damage and dysfunction.
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and narrowing...
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
Angina IV: Management01:26

Angina IV: Management

IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Angina II: Classification01:27

Angina II: Classification

Angina, also known as angina pectoris, is a chest pain resulting from diminished blood flow to the heart muscle and is often a symptom of coronary artery disease. Angina presents several variants with distinctive attributes, etiologies, and therapeutic approaches. The main types of angina include stable, unstable, variant (Prinzmetal's), microvascular, intractable, and silent ischemia.Stable angina is caused by atherosclerosis, which leads to the formation of plaques that narrow the coronary...